Ізраїль - іврит - Ministry of Health

teva pharmaceutical industries ltd, israel - rosuvastatin as calcium - טבליה - rosuvastatin as calcium 40 mg - rosuvastatin

Ізраїль - іврит - Ministry of Health

teva pharmaceutical industries ltd, israel - rosuvastatin as calcium - טבליה - rosuvastatin as calcium 5 mg - rosuvastatin

Ізраїль - іврит - Ministry of Health

teva israel ltd - sorafenib as tosylate - טבליות מצופות פילם - sorafenib as tosylate 200 mg - sorafenib

Ізраїль - іврит - Ministry of Health

teva israel ltd - rivaroxaban - טבליות מצופות פילם - rivaroxaban 10 mg - rivaroxaban

Ізраїль - іврит - Ministry of Health

teva israel ltd - rivaroxaban - טבליות מצופות פילם - rivaroxaban 2.5 mg - rivaroxaban

Ізраїль - іврит - Ministry of Health

teva israel ltd - dasatinib as monohydrate - טבליות מצופות פילם - dasatinib as monohydrate 100 mg - dasatinib

Ізраїль - іврит - Ministry of Health

teva israel ltd - dasatinib as monohydrate - טבליות מצופות פילם - dasatinib as monohydrate 20 mg - dasatinib

Ізраїль - іврит - Ministry of Health

teva israel ltd - dasatinib as monohydrate - טבליות מצופות פילם - dasatinib as monohydrate 50 mg - dasatinib

Ізраїль - іврит - Ministry of Health

teva israel ltd - dasatinib as monohydrate - טבליות מצופות פילם - dasatinib as monohydrate 70 mg - dasatinib

Ізраїль - іврит - Ministry of Health

teva israel ltd - lansoprazole - קפסולות - lansoprazole 30 mg - lansoprazole - lansoprazole - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (gord) or duodenal ulcer. prevention of relapse in patients with gord or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome. treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.